NASDAQ · Healthcare · Biotechnology
Mesoblast Limited
MESO
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. CEO Silviu Itescu · Market cap $1.9B.
$14.54
+0.10 · +0.69%
52w hi $21.5052w lo $9.88
Off 52w high 27.9%
73
NOTABLE
Current InsiderScore
Corp · 90d
10
10 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
3
0 strong · 3 notable
Analyst consensus
Strong Buy
Avg PT $11.50
Section 01
Recent Form 4 filings
10 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Apr 10 | Gregory George | Buy | 2,324,072 | $1.48 | +$3.44M | 70 | |
| Apr 09 | Gregory George | Buy | 105,000 | $1.46 | +$153K | 54 | |
| Apr 09 | Gregory George | Buy | 4,760 | $14.40 | +$69K | 37 | |
| Apr 09 | Gregory George | Buy | 5,000 | $14.30 | +$72K | 37 | |
| Apr 09 | Gregory George | Buy | 5,240 | $14.25 | +$75K | 37 | |
| Apr 09 | Gregory George | Buy | 20,000 | $1.43 | +$29K | 35 | |
| Apr 09 | Gregory George | Buy | 10,000 | $14.40 | +$144K | 54 | |
| Apr 09 | Gregory George | Buy | 886,890 | $1.43 | +$1.27M | 63 | |
| Apr 09 | Gregory George | Buy | 500,000 | $1.44 | +$720K | 57 | |
| Apr 04 | Gregory George | Buy | 4,000,000 | $1.42 | +$5.68M | 73 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay